Neuropeptidomics of mouse hypothalamus after imipramine treatment reveal somatostatin as a potential mediator of antidepressant effects
暂无分享,去创建一个
Per E. Andrén | Daniel Hoyer | Per Svenningsson | Maria Fälth | Karl Sköld | Anna Nilsson | P. Svenningsson | M. Fälth | D. Hoyer | Xiaoqun Zhang | K. Sköld | P. Andrén | Xiaoqun Zhang | N. Stroth | A. Nilsson | Hongshi Qi | Nikolas Stroth | Hongshi Qi | Karl Sköld | Maria Fälth
[1] L. Vécsei,et al. Effects of somatostatin-28 and some of its fragments and analogs on open-field behavior, barrel rotation, and shuttle box learning in rats , 1990, Psychoneuroendocrinology.
[2] Antidepressants Influence Somatostatin Levels and Receptor Pharmacology in Brain , 2009, Neuropsychopharmacology.
[3] P. Svenningsson,et al. Peptidomics-based discovery of novel neuropeptides. , 2003, Journal of proteome research.
[4] Y. Wong,et al. Activation of nuclear factor {kappa}B by somatostatin type 2 receptor in pancreatic acinar AR42J cells involves G{alpha}14 and multiple signaling components: a mechanism requiring protein kinase C, calmodulin-dependent kinase II, ERK, and c-Src. , 2005, The Journal of biological chemistry.
[5] T. Troxler,et al. SRA880, in vitro characterization of the first non-peptide somatostatin sst(1) receptor antagonist. , 2004, Neuroscience letters.
[6] Christian Bruns,et al. Opportunities in somatostatin research: biological, chemical and therapeutic aspects , 2003, Nature Reviews Drug Discovery.
[7] G. Fink,et al. Somatostatin-28 is an hormonally active peptide secreted into hypophysial portal vessel blood , 1983, Brain Research.
[8] G. Fink,et al. Somatostatin-28(1-12)-like immunoreactive substance is secreted into hypophysial portal vessel blood in the rat. , 1984, Neuroendocrinology.
[9] P. Svenningsson,et al. Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[10] D. Hoyer,et al. The somatostatin sst1 receptor: an autoreceptor for somatostatin in brain and retina? , 2006, Pharmacology & therapeutics.
[11] U. Lepola,et al. Long-term effects of alprazolam and imipramine on cerebrospinal fluid monoamine metabolites and neuropeptides in panic disorder. , 1989, Neuropsychobiology.
[12] N. Yamada,et al. Chronic administration of tricyclic antidepressants suppresses hypothalamo-pituitary-adrenocortical activity in male rats , 1988, Psychoneuroendocrinology.
[13] J. Morgan,et al. Isolation and sequencing of two cerebellum-specific peptides. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[14] A. Grossman,et al. THE PITUITARY‐ADRENAL RESPONSE TO CRF‐41 IS UNALTERED BY INTRAVENOUS SOMATOSTATIN IN NORMAL SUBJECTS , 1989, Clinical endocrinology.
[15] P. Greengard,et al. Diverse Psychotomimetics Act Through a Common Signaling Pathway , 2003, Science.
[16] Leonid Zamdborg,et al. Endogenous Peptide Discovery of the Rat Circadian Clock a Focused Study of the Suprachiasmatic Nucleus by Ultrahigh Performance Tandem Mass Spectrometry* □ S , 2022 .
[17] Q. Pittman,et al. Somatostatin(14) and -(28) but not somatostatin(1–12) hyperpolarize CA1 pyramidal neurons in vitro , 1988, Brain Research.
[18] G. Chrousos. Stress and disorders of the stress system , 2009, Nature Reviews Endocrinology.
[19] D. O'Connor,et al. The chromogranin-secretogranin family. , 2003, The New England journal of medicine.
[20] P. Greengard,et al. Regulation of Phosphorylation of the GluR1 AMPA Receptor in the Neostriatum by Dopamine and Psychostimulants In Vivo , 2000, The Journal of Neuroscience.
[21] George Paxinos,et al. The Mouse Brain in Stereotaxic Coordinates , 2001 .
[22] J. Cryan,et al. The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice , 2005, Neuroscience & Biobehavioral Reviews.
[23] J. Herman,et al. Neural regulation of endocrine and autonomic stress responses , 2009, Nature Reviews Neuroscience.
[24] C. Dickson,et al. Anxiolytic and antidepressant effects of intracerebroventricularly administered somatostatin: Behavioral and neurophysiological evidence , 2008, Neuroscience.
[25] Fa-Yun Che,et al. Optimization of neuropeptide extraction from the mouse hypothalamus. , 2007, Journal of proteome research.
[26] D. Hoyer,et al. The somatostatin receptor (sst1) modulates the release of somatostatin in the nucleus accumbens of the rat , 2004, Neuropharmacology.
[27] D. Hoyer,et al. SRA880, in vitro characterization of the first non-peptide somatostatin sst1 receptor antagonist , 2004, Neuroscience Letters.
[28] I. Lucki,et al. Limitations on the use of the C57BL/6 mouse in the tail suspension test , 2001, Psychopharmacology.
[29] M. Herkenham,et al. St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats , 2001, Molecular Psychiatry.
[30] David Fenyö,et al. An automated method for scanning LC-MS data sets for significant peptides and proteins, including quantitative profiling and interactive confirmation. , 2007, Journal of proteome research.
[31] H. Gershenfeld,et al. An exploratory factor analysis of the Tail Suspension Test in 12 inbred strains of mice and an F2 intercross , 2003, Brain Research Bulletin.
[32] P. Schoeffter,et al. Regulation of CRH-induced secretion of ACTH and corticosterone by SOM230 in rats. , 2005, European journal of endocrinology.
[33] G. Bissette,et al. Somatostatin in Alzheimer's disease and depression. , 1992, Life sciences.
[34] F. Bloom,et al. Evidence for selective release of somatostatin-14 and somatostatin-28(1- 12) from rat hypothalamus , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[35] E. Krause,et al. The Degradation of Corticotropin-releasing Factor by Enzymes of the Rat Brain Studied by Liquid Chromatography–Mass Spectrometry , 1998, Peptides.
[36] N. Ling,et al. Primary structure of ovine hypothalamic somatostatin-28 and somatostatin-25. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[37] P. Svenningsson,et al. The significance of biochemical and molecular sample integrity in brain proteomics and peptidomics: Stathmin 2‐20 and peptides as sample quality indicators , 2007, Proteomics.
[38] W. Vale,et al. Central nervous system regulation of adrenocorticotropin secretion: role of somatostatins. , 1984, Endocrinology.
[39] S. Bloom,et al. Cerebellin-like peptide: TIssue distribution in rat and guinea-pig and its release from rat cerebellum, hypothalamus and cerebellar synaptosomes in vitro , 1988, Neuroscience.
[40] P. Dutar,et al. Somatostatin receptor subtypes 2 and 4 affect seizure susceptibility and hippocampal excitatory neurotransmission in mice , 2002, The European journal of neuroscience.
[41] M. Herkenham,et al. Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications. , 1991, The Journal of clinical investigation.
[42] D. Hoyer,et al. Embryonic and postnatal mRNA distribution of five somatostatin receptor subtypes in the rat brain , 1995, Neuropharmacology.
[43] D. Rubinow,et al. CSF somatostatin in affective illness and normal volunteers , 1985, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[44] F. Petraglia,et al. SOMATOSTATIN AND OXYTOCIN INFUSION INHIBITS THE RISE OF PLASMA β‐ENDORPHIN, β‐LIPOTROPHIN AND CORTISOL INDUCED BY INSULIN HYPOGLYCAEMIA , 1986, Clinical endocrinology.
[45] Masahiko Watanabe,et al. Distinct expression of Cbln family mRNAs in developing and adult mouse brains , 2006, The European journal of neuroscience.
[46] P. Svenningsson,et al. Striatal Alterations of Secretogranin-1, Somatostatin, Prodynorphin, and Cholecystokinin Peptides in an Experimental Mouse Model of Parkinson Disease*S , 2009, Molecular & Cellular Proteomics.
[47] A. Morel,et al. The somatostatin-28 convertase of rat brain cortex generates both somatostatin-14 and somatostatin-28. , 1985, Biochemical and biophysical research communications.
[48] D. Treit,et al. Anxiolytic and antidepressant actions of somatostatin: the role of sst2 and sst3 receptors , 2009, Psychopharmacology.
[49] K. Chihara,et al. Repeated administration of antidepressant drugs reduces regional somatostatin concentrations in rat brain. , 1992, Journal of affective disorders.
[50] Burton S. Rosner,et al. Neuropharmacology , 1958, Nature.
[51] David Fenyö,et al. Neuropeptidomics Strategies for Specific and Sensitive Identification of Endogenous Peptides*S , 2007, Molecular & Cellular Proteomics.
[52] G. Koob,et al. Neurobiological Similarities in Depression and Drug Dependence: A Self-Medication Hypothesis , 1998, Neuropsychopharmacology.
[53] J. Champagnat,et al. Somatostatin depresses excitability in neurons of the solitary tract complex through hyperpolarization and augmentation of IM, a non-inactivating voltage-dependent outward current blocked by muscarinic agonists. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[54] Dennis C. Choi,et al. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo–pituitary–adrenocortical responsiveness , 2003, Frontiers in Neuroendocrinology.
[55] B. Penke,et al. Somatostatin28(15–28), but not somatostatin28(1–12), affects central monoaminergic neurotransmission in rats , 1990, Neuropeptides.
[56] G. Chrousos,et al. Chronic imipramine is associated with diminished hypothalamic-pituitary-adrenal axis responsivity in healthy humans. , 1997, The Journal of clinical endocrinology and metabolism.
[57] J. Licinio,et al. The prototypic antidepressant drug, imipramine, but not Hypericum perforatum (St. John's Wort), reduces HPA-axis function in the rat. , 2003, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[58] W. Vale,et al. Corticotropin Releasing Factor (CRF) Binding Protein: A Novel Regulator of CRF and Related Peptides , 1995, Frontiers in Neuroendocrinology.
[59] Xiaorong Zhu,et al. Analysis of peptides in prohormone convertase 1/3 null mouse brain using quantitative peptidomics , 2010, Journal of neurochemistry.
[60] R. Duman,et al. A Neurotrophic Model for Stress-Related Mood Disorders , 2006, Biological Psychiatry.